Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Participants on semaglutide were slightly more likely to drop out of the trial than those taking the placebo
Pfizer reports earnings later this month, giving analysts a chance to further probe the drugmaker on the results of the study released Thursday and its future in obesity
J.Diaz-VivancosP.RubioM.FernandezN.HernndezJ
Dipeptidyl peptidase 4 (DPP-4) inhibitors inhibit DPP-4, which is a ubiquitous enzyme expressed on the surface of most cell types that deactivates GLP-1
This finding was a result of an analysis conducted on the PIONEER and SUSTAIN serial trials, which studied the drugs effectiveness
US$ 29.67
US$ 26.07
US$ 20.44
